Science and Health News

Triptans, a commonly prescribed class of migraine drugs, may also be useful in treating obesity, a new study by scientists at UT Southwestern suggests.

The most effective way to tackle obesity is to reduce food consumption, but obese people often encounter difficulties in regulating their dietary habits as they lose their sense of satiety. Identifying a factor that specifically controls body weight, and investigating how it regulates our sense of satiety, is crucial for the development of therapeutic approaches for obesity.

Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study 63% of participants taking tirzepatide 15 mg achieved at least 20% body weight reductions as a key secondary endpoint

Perspective published in The American Journal of Clinical Nutrition argues the root causes of the obesity epidemic are more related to what we eat rather than how much we eat

Like a good story, feeding has a beginning, a middle and an end. It begins with appetite prompting the search for food, continues with eating the food and it ends when satiation hits and the consumption of food is stopped.

New research shows that liver-focused ultrasound stimulation significantly decreases chronic inflammation linked to obesity. In a study published today in Scientific Reports, researchers from the Feinstein Institutes for Medical Research and GE Research demonstrate that ultrasound technology could be used as a noninvasive approach to treating obesity. These findings are important as they present breakthrough noninvasive methods to tap into the nervous system to treat metabolic diseases without the use of pharmaceuticals.